Press Releases Year None2024202320222021202020192018 Jan 29, 2024 Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older Jan 16, 2024 Vaxcyte Appoints Whitney Jones as Chief People Officer Jan 04, 2024 Vaxcyte Provides Clinical and Regulatory Progress Update on Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) Franchise Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Displaying 21 - 23 of 23
Year None2024202320222021202020192018 Jan 29, 2024 Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older Jan 16, 2024 Vaxcyte Appoints Whitney Jones as Chief People Officer Jan 04, 2024 Vaxcyte Provides Clinical and Regulatory Progress Update on Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) Franchise Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Displaying 21 - 23 of 23
